Position in PASG
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$180,686
-$144,146 QoQ
Shares Held
37,026
-10.5% QoQ
Ownership
1.15%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#9
of 30 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PASG Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $21,870,628,057 across 520 Biotechnology names. PASG ranks #408 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,017,848 | $2,989,245,636 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,625,810 | $1,637,297,566 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,635,840 | $793,466,914 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,942,676 | $738,384,360 | |
| 5 | MRNA |
Moderna, Inc.
|
9,710,335 | $680,014,759 | |
| 6 | INCY |
Incyte Corp
|
4,750,735 | $538,543,319 | |
| 7 | RPRX |
Royalty Pharma plc
|
8,058,048 | $451,814,751 | |
| 8 | INSM |
INSMED Inc
|
4,220,155 | $449,952,925 |
All Filings in PASG
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $180,686 | 37,026 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $324,832 | 41,380 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $370,484 | 31,397 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $219,082 | 27,283 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $215,430 | 538,578 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $192,773 | 546,101 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $301,397 | 531,565 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $356,660 | 509,516 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $342,300 | 431,110 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $518,775 | 384,278 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $335,525 | 332,203 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $218,589 | 332,203 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $312,331 | 331,914 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $317,973 | 331,914 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $458,041 | 331,914 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $440,671 | 352,537 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $830,075 | 351,727 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $2,000,464 | 645,311 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $4,269,263 | 672,325 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $4,714,346 | 473,328 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $7,005,217 | 529,095 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $7,769,685 | 444,490 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $8,211,012 | 321,119 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $2,802,223 | 213,747 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $5,779,229 | 211,461 | Shares | Defined | 2020-08-13 | |
| No filing history on record for this holder in this stock. | ||||||